首页|乌梅丸对乳腺癌小鼠原位瘤微环境基因表达谱及免疫相关基因表达的影响

乌梅丸对乳腺癌小鼠原位瘤微环境基因表达谱及免疫相关基因表达的影响

扫码查看
目的:通过研究乌梅丸对乳腺癌小鼠原位瘤微环境基因表达谱及免疫相关基因表达的影响,探讨乌梅丸抑制乳腺癌的作用机制.方法:通过在小鼠第2对乳腺脂肪垫内注射4T1乳腺癌细胞构建乳腺癌小鼠模型.模型分为乌梅丸高(32.88 g/kg)、低(16.44 g/kg)剂量组及阳性对照组(卡培他滨,359mg/kg)、空白对照组,给予相应药物灌胃.通过观测小鼠原位乳腺癌的体积、瘤重、抑瘤率判断药物的抑瘤效应.通过基因表达谱芯片技术检测原位瘤微环境中基因表达谱的特征,并采用生物信息学方法分析基因表达谱的GO和KEGG通路特点;比较药物观察组(即抑瘤效果较好的乌梅丸低剂量组)乌梅丸和阳性对照组(卡培他滨)在基因表达影响方面的差异.采用RT-PCR、免疫组织化学和蛋白质印迹方法分析了乌梅丸所影响的免疫相关基因的表达情况.结果:乌梅丸高、低剂量组在瘤体积、瘤重和抑瘤率方面虽然效果不如阳性对照组,但与空白对照组比较仍显示具有一定的抑瘤效果;乌梅丸低剂量组效果略优于乌梅丸高剂量组.乌梅丸干预后共有54条差异基因,其中上调基因30条,下调基因24条;卡培他滨干预后共有104条差异基因,其中上调基囚54条,下调基因50条;两者只有1条差异基因相同.乌梅丸调控的基因涉及152个GO项,而卡培他滨只涉及9个GO项;乌梅丸涉及的KEGG通路3条,卡培他滨涉及1条.与空白对照组比较,乌梅丸干预后免疫相关基因Bmp4、Fzd9、Capn3、Fndc5、Sfpq mRNA和蛋白表达下降,但Slc15a3、Tnfsf13b、Il1a mRNA表达上升,而蛋白下降.结论:乌梅丸能一定程度上抑制乳腺癌的生长;乌梅丸对乳腺癌组织微环境中基因表达的影响,与西药卡培他滨完全不同,涉及更多的生物学过程、细胞组分、分子功能,调控更为广泛;乌梅丸能下调免疫相关基因Bmp4、Fzd9、Capn3、Fndc5、Sfpq的表达,对Slc15a3、Tnfsf13b、Il1a表达的影响还需进一步分析,乌梅丸对乳腺癌小鼠原位瘤微环境中基因表达的调控作用可能是其发挥抑瘤作用的机制之一.
Effects of Wumei Pills on gene microenvironment expression profile and immune related gene expression in orthotopic tumor of breast cancer mice
Objective:To study the effect of Wumei Pills on the gene expression profile of in situ tumor microenvironment and immune related gene expression in breast cancer mice,and to explore the mechanism of Wumei Pills in inhibiting breast cancer.Methods:The mouse model of breast cancer was established by injecting 4T1 breast cancer cells into the second breast fat pad of mice.The model was divided into high-dose Wumei Pills group(32.88 g/kg),low-dose Wumei Pills group(16.44 g/kg),drug control group(Capecitabine,359 mg/kg)and blank control group.By observing the tumor volume,weight and inhibition rate of in situ breast cancer in mice,the tumor inhibition effect of the drug was judged.The characteristics of gene expression profiles in the microenvironment of orthotopic tumors were detected by gene expression profiling chip technology,and the GO and KEGG pathway characteristics of gene expression profiles were analyzed by bioinformatics methods.To compare the effect of Wumei Pills and Capecitabine on gene expression.RT-PCR,immunohistochemistry and Western Blot were used to analyze the expression of immune related genes affected by Wumei Pills.Results:Although the high-dose and low-dose Wumei Pills group were inferior to the drug observation group in tumor volume,weight and inhibition rate,there still showed a certain tumor inhibition effect compared with the blank control group.Among them,the effect of the low-dose Wumei Pills group was slightly better than that of the high-dose Wumei Pills group.After Wumei Pills intervention,there were 54 differential genes,including 30 up-regulated genes and 24 down-regulated genes.There were 104 differential genes after capecitabine intervention,including 54 up-regulated genes and 50 down regulated genes.There was only one difference gene between them.The genes regulated by Wumei Pills involved 152 GO items,while Capecitabine only involved 9 GO items.There were three KEGG pathways involved in Wumei Pills and one involved in Capecitabine.After Wumei Pills intervention,compared with the blank control group,the mRNA and protein expression of immune related genes Bmp4,Fzd9,Capn3,Fndc5 and Sfpq decreased,but the mRNA expression of Slc15a3,Tnfsf13b and Il1a increased,while the protein expression decreased.Conclusion:Wumei Pills can inhibit the growth of breast cancer to some extent.The effect of Wumei Pills on gene expression in the microenvironment of breast cancer tissue is completely different from that of Capecitabine,which involves more biological processes,cell components,molecular functions,and the regulation is more extensive.Wumei Pills can down regulate the expression of immune related genes Bmp4,Fzd9,Capn3,Fndc5 and Sfpq,and its effect on the expression of Slc15a3,Tnfsf13b and Il1a needs further analysis.It can be seen that the regulatory effect of Wumei Pills on gene expression in the microenvironment of breast cancer in situ may be one of the mechanisms of its anti-tumor effect.

Wumei PillsBreast cancerMicroenvironmentGene expression profileImmune function regulationMechanismBioinformatics

王萍、李锦超、任美玲、吴紫葶、杨海燕

展开 >

江西中医药大学中医学院,南昌 330004

乌梅丸 乳腺癌 微环境 基因表达谱 免疫功能调节 机制 生物信息学

江西省自然科学基金项目国家自然科学基金项目江西省教育厅科技项目江西中医药大学科技创新团队发展项目

20202BABL20612981703980209804CXTD22016

2024

中华中医药杂志
中华中医药学会

中华中医药杂志

CSTPCD北大核心
影响因子:1.135
ISSN:1673-1727
年,卷(期):2024.39(2)
  • 21